Shares for Beginners podcast interview with Sharesight CEO
Sharesight user and share investing advocate Philip Muscatello spoke with Sharesight CEO Doug Morris on the Shares for Beginners podcast about the changing face of financial services, the tax complexity of ETFs, benchmarking and Sharesight.
Listen to the Shares for Beginners podcast with Sharesight
This episode of the Shares for Beginners podcast featuring Sharesight’s Doug Morris covers:
- The history and features of Sharesight
- Morningstar research
- Benchmarking
- Tax treatment of ETFs
- The changing shape of the financial services industry
- Annualised performance
- Index hugging
Listen to, or download the podcast below:
Track your share portfolio with Sharesight
Sharesight is the ultimate tool for tracking your share portfolio - for both beginner and experienced investors alike;:
- Get the true picture of your investment performance, including the impact of brokerage fees, dividends, and capital gains with Sharesight’s annualised performance calculation methodology
- Sharesight automatically tracks your daily price & currency fluctuations, as well as handles corporate actions such as dividends and share splits
- Run powerful tax reports built for investors, including, Capital Gains Tax (Australia and Canada) Traders Tax (NZ) and FIF foreign investment fund income reports (NZ)
Sharesight is FREE for users with less than 10 shares, just sign up for a Sharesight account and get started tracking your investments today.
FURTHER READING
See what’s inside your ETFs with Sharesight’s exposure report
See inside your ETFs and get the full picture of your investment portfolio's composition with Sharesight's exposure report.
How KmacD Financial streamlines reporting and saves time with Sharesight
We talk to financial planning firm KmacD Financial about how the Sharesight-AdviserLogic integration helps them save time and streamline client reporting.
Sharesight product updates – November 2023
The focus over the past month has been on implementing additional feature ideas relating to our new (beta) exposure report.